Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.

Ítems similars

• Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.
  per: Crawley, A C, et al.
  Publicat: (1998)
• Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.
  per: Crawley, A C, et al.
  Publicat: (1996)
• Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme(®)) therapy
  per: Braunlin, E., et al.
  Publicat: (2012)
• Enzyme replacement therapy for murine mucopolysaccharidosis type VII.
  per: Sands, M S, et al.
  Publicat: (1994)
• Anti-TNF-Alpha Therapy Enhances the Effects of Enzyme Replacement Therapy in Rats with Mucopolysaccharidosis Type VI
  per: Eliyahu, Efrat, et al.
  Publicat: (2011)